[go: up one dir, main page]

EA199900675A3 - Полиморф моногидрата зополрестата - Google Patents

Полиморф моногидрата зополрестата

Info

Publication number
EA199900675A3
EA199900675A3 EA199900675A EA199900675A EA199900675A3 EA 199900675 A3 EA199900675 A3 EA 199900675A3 EA 199900675 A EA199900675 A EA 199900675A EA 199900675 A EA199900675 A EA 199900675A EA 199900675 A3 EA199900675 A3 EA 199900675A3
Authority
EA
Eurasian Patent Office
Prior art keywords
zopolestation
polymerphonography
polymerphonography zopolestation
Prior art date
Application number
EA199900675A
Other languages
English (en)
Other versions
EA199900675A2 (ru
Inventor
Джон Фрэнсис Ламберт
Тимоти Норрис
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA199900675A2 publication Critical patent/EA199900675A2/ru
Publication of EA199900675A3 publication Critical patent/EA199900675A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
EA199900675A 1998-08-21 1999-08-20 Полиморф моногидрата зополрестата EA199900675A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9747498P 1998-08-21 1998-08-21

Publications (2)

Publication Number Publication Date
EA199900675A2 EA199900675A2 (ru) 2000-02-28
EA199900675A3 true EA199900675A3 (ru) 2000-06-26

Family

ID=22263562

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900675A EA199900675A3 (ru) 1998-08-21 1999-08-20 Полиморф моногидрата зополрестата

Country Status (31)

Country Link
US (1) US6159976A (ru)
EP (1) EP0982306A3 (ru)
JP (1) JP2000072769A (ru)
KR (1) KR20000017411A (ru)
CN (1) CN1245804A (ru)
AP (1) AP9901662A0 (ru)
AU (1) AU4453299A (ru)
BG (1) BG103674A (ru)
BR (1) BR9903873A (ru)
CA (1) CA2280590A1 (ru)
EA (1) EA199900675A3 (ru)
EE (1) EE9900385A (ru)
GT (1) GT199900137A (ru)
HR (1) HRP990259A2 (ru)
HU (1) HUP9902783A3 (ru)
ID (1) ID23307A (ru)
IL (1) IL131419A0 (ru)
IS (1) IS5155A (ru)
MA (1) MA26678A1 (ru)
NO (1) NO994027L (ru)
NZ (1) NZ337363A (ru)
OA (1) OA11150A (ru)
PA (1) PA8480601A1 (ru)
PE (1) PE20000993A1 (ru)
PL (1) PL335016A1 (ru)
SG (1) SG83147A1 (ru)
TN (1) TNSN99159A1 (ru)
TR (1) TR199901996A2 (ru)
UY (1) UY25668A1 (ru)
YU (1) YU39899A (ru)
ZA (1) ZA995297B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
EP3597650B1 (en) 2010-07-16 2022-09-07 The Trustees of Columbia University in the City of New York Aldose reductase inhibitors and uses thereof
WO2014126885A1 (en) * 2013-02-13 2014-08-21 Mylari Banavara L Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
IL304979A (en) 2016-06-21 2023-10-01 Univ Columbia Aldose reductase inhibitors and methods of using them
CN111065392B (zh) 2017-07-28 2024-10-25 应用治疗公司 用于治疗半乳糖血症的组合物和方法
AU2020254610A1 (en) 2019-04-01 2021-11-18 Applied Therapeutics Inc. Inhibitors of aldose reductase
WO2020227430A1 (en) 2019-05-07 2020-11-12 University Of Miami Treatment and detection of inherited neuropathies and associated disorders
WO2021202523A1 (en) 2020-03-31 2021-10-07 Applied Therapeutics, Inc. Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy
KR20230005944A (ko) 2020-05-01 2023-01-10 어플라이드 테라퓨틱스 인크. 소르비톨 데히드로게나제 결핍 치료를 위한 알도스 리덕타제 억제제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748280A (en) * 1985-11-07 1988-05-31 Pfizer Inc. Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
US6127367A (en) * 1996-02-29 2000-10-03 Pfizer, Inc. Method of reducing tissue damage associated with non-cardiac ischemia

Also Published As

Publication number Publication date
ZA995297B (en) 2001-02-19
CN1245804A (zh) 2000-03-01
HU9902783D0 (en) 1999-10-28
SG83147A1 (en) 2001-09-18
EA199900675A2 (ru) 2000-02-28
BR9903873A (pt) 2000-09-19
US6159976A (en) 2000-12-12
HUP9902783A3 (en) 2001-01-29
TNSN99159A1 (fr) 2005-11-10
EP0982306A3 (en) 2000-07-05
GT199900137A (es) 2001-02-09
HUP9902783A2 (hu) 2000-12-28
TR199901996A2 (xx) 2000-03-21
CA2280590A1 (en) 2000-02-21
OA11150A (en) 2003-04-16
EE9900385A (et) 2000-04-17
IL131419A0 (en) 2001-01-28
IS5155A (is) 2000-02-22
JP2000072769A (ja) 2000-03-07
NO994027L (no) 2000-02-22
NZ337363A (en) 2001-01-26
NO994027D0 (no) 1999-08-20
AU4453299A (en) 2000-03-09
AP9901662A0 (en) 1999-09-30
HRP990259A2 (en) 2000-06-30
PE20000993A1 (es) 2000-10-04
PL335016A1 (en) 2000-02-28
KR20000017411A (ko) 2000-03-25
PA8480601A1 (es) 2000-09-29
YU39899A (sh) 2002-12-10
EP0982306A2 (en) 2000-03-01
UY25668A1 (es) 2001-08-27
BG103674A (en) 2000-03-31
MA26678A1 (fr) 2004-12-20
ID23307A (id) 2000-04-05

Similar Documents

Publication Publication Date Title
DE69919529D1 (de) Lungevenenablationskatheter
NO20010382L (no) Agglutineringsundersökelse
DE69908817D1 (de) Laderaum
DE69906397D1 (de) Benzosulfonderivate
DE69910321D1 (de) Funkempfangspeilantennengerät
DE69922063D1 (de) Fesselballon
DE69910986D1 (de) Atmosphärenteilchenanalysator
DE69931392D1 (de) Hautdepigmentierungsmittel
DE69910080D1 (de) Anstreichapparat
DE69930626D1 (de) Sorptionsreinigungstuch
DE69901852D1 (de) Perfluorodioxolen
DE69941474D1 (de) Lichtstrahlabtastgerät
DE69922729D1 (de) Achsschubausgleich
DE69924068D1 (de) Gasfederfüllventil
FI980739A0 (fi) Timmerknut
FI980316A0 (fi) Foerfarande foer dataoeverfoering
DE69902306D1 (de) Schwellwertventil
EA199900675A3 (ru) Полиморф моногидрата зополрестата
FI982246A0 (fi) Kasvisterolijohdannaisia
FI982648A0 (fi) Linkopaketti
FI980548A0 (fi) Avvattningselement foer en pappers- eller kartongmaskin
FI103298B (fi) Imutuuletuslaite
FI3836U1 (fi) Hirsirakenne
FI981200A0 (fi) Pikatelinekannatin
DK199801629A (da) Låsehus